Lean Mass Synthesis Pathways are the intricate, interconnected intracellular signaling cascades that govern the process of protein synthesis and cellular accretion within skeletal muscle and other non-fat tissues. These pathways represent the biochemical machinery responsible for hypertrophy and tissue repair, making them critical targets for clinical interventions aimed at reversing sarcopenia and improving metabolic health. Their activity is directly responsive to mechanical loading, nutrient availability, and anabolic hormone levels.
Origin
This term is a composite from molecular biology, exercise physiology, and clinical nutrition. Lean Mass is a physiological term for muscle, bone, and organs, and Synthesis Pathways refers to the biochemical routes of anabolism. The term gained prominence with the discovery and detailed mapping of key intracellular regulators of muscle growth.
Mechanism
The primary mechanism involves the mechanistic Target of Rapamycin (mTOR) signaling pathway, which acts as a master regulator of protein translation. Anabolic signals, such as insulin and IGF-1 binding to their receptors, activate the Akt/PKB kinase, which in turn phosphorylates and activates mTOR. Once activated, mTOR promotes the translation of messenger RNA into new proteins, thereby increasing muscle fiber size and overall lean tissue mass.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.